Literature DB >> 17330946

Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease.

Anna Shkoda1, Tanja Werner, Hannelore Daniel, Manuela Gunckel, Gerhard Rogler, Dirk Haller.   

Abstract

The loss of intestinal epithelial cell (IEC) function is a critical component in the initiation and perpetuation of chronic intestinal inflammation in the genetically susceptible host. We applied proteome analysis (PA) to characterize changes in the protein expression profile of primary IEC from patients with Crohn's disease (CD) and ulcerative colitis (UC). Surgical specimens from 18 patients with active CD (N = 6), UC (N = 6), and colonic cancer (N = 6) were used to purify primary IEC from ileal and colonic tissues. Changes in protein expression were identified using 2D-gel electrophoreses (2D SDS-PAGE) and peptide mass fingerprinting via MALDI-TOF mass spectrometry (MS) as well as Western blot analysis. PA of primary IEC from inflamed ileal tissue of CD patients and colonic tissue of UC patients identified 21 protein spots with at least 2-fold changes in steady-state expression levels compared to the noninflamed tissue of control patients. Statistical significance was achieved for 9 proteins including the Rho-GDP dissociation inhibitor alpha that was up-regulated in CD and UC patients. Additionally, 40 proteins with significantly altered expression levels were identified in IEC from inflamed compared to noninflamed tissue regions of single UC (N = 2) patients. The most significant change was detected for programmed cell death protein 8 (7.4-fold increase) and annexin 2A (7.7-fold increase). PA in primary IEC from IBD patients revealed significant expression changes of proteins that are associated with signal transduction, stress response as well as energy metabolism. The induction of Rho GDI alpha expression may be associated with the destruction of IEC homeostasis under condition of chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330946     DOI: 10.1021/pr060433m

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  46 in total

Review 1.  Proteomics and systems biology: current and future applications in the nutritional sciences.

Authors:  J Bernadette Moore; Mark E Weeks
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

Review 2.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 3.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 4.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

5.  Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation.

Authors:  Sandra Heller; Harrison M Penrose; Chloe Cable; Debjani Biswas; Hani Nakhoul; Melody Baddoo; Erik Flemington; Susan E Crawford; Suzana D Savkovic
Journal:  FASEB J       Date:  2017-02-09       Impact factor: 5.191

6.  Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Xiao-Jun Zhang; Feung Ping Leung; Wendy Wl Hsiao; Shun Tan; Shao Li; Hong-Xi Xu; Joseph Jy Sung; Zhao-Xiang Bian
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 7.  Monitoring host responses to the gut microbiota.

Authors:  Joshua S Lichtman; Justin L Sonnenburg; Joshua E Elias
Journal:  ISME J       Date:  2015-06-09       Impact factor: 10.302

8.  Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis.

Authors:  Erin H Seeley; Mary K Washington; Richard M Caprioli; Amosy E M'Koma
Journal:  Proteomics Clin Appl       Date:  2013-05-08       Impact factor: 3.494

Review 9.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

10.  NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells.

Authors:  Alice Y Chuang; Jim C Chuang; Zili Zhai; Feng Wu; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.